Jirong Wang

ORCID: 0000-0003-4223-3497
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ferroptosis and cancer prognosis
  • Cancer, Lipids, and Metabolism
  • Epigenetics and DNA Methylation
  • Ubiquitin and proteasome pathways
  • Renal cell carcinoma treatment
  • Genetic Associations and Epidemiology
  • FOXO transcription factor regulation
  • Neuroblastoma Research and Treatments

Lanzhou University
2022-2025

Lanzhou University Second Hospital
2022-2025

The plasma proteins are an important source of therapeutic targets. This study aims to address the diagnostic and challenges bladder cancer (BC) by using Mendelian randomization (MR) with a large sample size from multiple centers identify which causally related pathogenesis BC. Followed merging nine protein datasets six studies, total 5538 three BC (ieu-b-4874, ukb-b-8193, FinnGen_R11_C3_ BLADDER_EXALL) were used perform proteome‑wide MR estimate contribution BC, separately. To ensure...

10.1007/s12672-025-02476-5 article EN cc-by-nc-nd Discover Oncology 2025-05-02

Clear cell renal carcinoma (ccRCC) is one of the most common diseases in world, with high morbidity and mortality. Recent studies have revealed important role SPC24, a subunit Ndc80 complex, occurrence development carcinoma. However, latent effect SPC24 progress ccRCC remains to be further explored. The intent this research investigate whether can used as an index predict progression explore its relationship immune microenvironment pan-cancer.Based on data from public databases, we...

10.2147/ijgm.s348859 article EN cc-by-nc International Journal of General Medicine 2022-01-01
Coming Soon ...